Skip to main content

Laura Ludovica Gramegna .

Laura Ludovica Gramegna, MD, neuroradiologist and principal investigator of the Stroke Research Group. My work integrates translational neuroscience, interventional neuroradiology, and advanced neuroimaging. I lead multidisciplinary projects translating molecular knowledge of cerebral vascular malformations into innovative treatments. I coordinate clinical trials in interventional neuroradiology and develop MRI- and CT-based biomarkers for ischaemic and haemorrhagic vascular diseases.

Institutions of which they are part

Postdoctoral researcher
Stroke research
Vall Hebron Institut de Recerca
Laura Ludovica Gramegna .

Laura Ludovica Gramegna .

Laura Ludovica Gramegna .

Institutions of which they are part

Postdoctoral researcher
Stroke research
Vall Hebron Institut de Recerca

Laura Ludovica Gramegna, MD, neuroradiologist and principal investigator of the Stroke Research Group. My work integrates translational neuroscience, interventional neuroradiology, and advanced neuroimaging. I lead multidisciplinary projects translating molecular knowledge of cerebral vascular malformations into innovative treatments. I coordinate clinical trials in interventional neuroradiology and develop MRI- and CT-based biomarkers for ischaemic and haemorrhagic vascular diseases.

I graduated in medicine in 2012, specialised in neuroradiology in 2017, and obtained a PhD in Neuroscience in 2023.
As a lecturer at the University of Bologna, I combined teaching, clinical practice, and research. I have expertise in neurological disease pathophysiology, genetics, and advanced neuroimaging biomarkers, and trained at University Medical Center Hamburg-Eppendorf (UKE). I have also trained in design thinking to address complex problems through empathy, creativity, and experimentation.
I collaborate with VHIR groups, particularly the Interventional Neuroradiology Research Team led by Dr Alejandro Tomasello, and with Barcelona institutions, including IRSJD, ICN2, the University of Barcelona, and Hospital del Mar. I also participate in international projects with the University of Bologna and the university hospitals of Oxford and Cambridge.
I currently coordinate three research projects funded through public-private partnerships, including CaixaResearch Health, and co-supervise doctoral theses and master's dissertations. I am the author or co-author of 68 high-impact publications and have an h-index of 20.
My research focuses on innovative, minimally invasive therapies for cerebral arteriovenous malformations, the glymphatic system in dural fistulas, and clinical trials on cerebral aneurysms. I also advance neuroradiological image analysis to develop clinically applicable biomarkers for vascular and neurodegenerative diseases.
My main scientific contribution is a multidisciplinary, translational approach that integrates diverse perspectives to address complex clinical challenges, including molecular treatments for cerebral arteriovenous malformations.

Related news

Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research

The study analyzes a new therapeutic strategy in high-risk patients that could influence future international clinical guidelines

The Stroke Research and the Neurovascular Diseases groups lead innovative research projects in both clinical and translational areas.

Related professionals

Marta Vila Salvador

Marta Vila Salvador

Research technician
Microbiology
Read more
Laura  Hernandez  Castro

Laura Hernandez Castro

Research technician
Multidisciplinary Nursing Research Group
Read more
Laura Vidal Piñeiro

Laura Vidal Piñeiro

Research technician
General Surgery
Read more
Albert Gil Vila

Albert Gil Vila

Predoctoral researcher
Systemic Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.